EGIS-7625

EGIS-7625
Clinical data
ATC code	none
Legal status
Legal status	UN: Unscheduled;
Identifiers
	IUPAC name 5-(4-benzylpiperazin-1-yl)-2-methyl-4-nitroaniline;
CAS Number	755040-97-2
PubChem (CID)	9930789
ChEMBL	CHEMBL1628720
Chemical and physical data
Formula	C18H22N4O2
Molar mass	326.17 g/mol

EGIS-7625 is a selective and competitive 5-HT_2B receptor antagonist. It is experimentally proven to be directly associated with smooth stomach muscle construction of white rats in vivo, and variably effective in provoking a similar response in in vitro human stomach cells. In high blood concentrations, it causes mild constriction of rabbit pulmonary arteries.^[1]

References[edit]

^ Kovács, Anikó; Gacsályi, Istvan; Wellmann, János; Schmidt, Éva; Szücs, Zsuzsanna; Dubreuil, Valérie; Nicolas, Jean Paul; Boutin, Jean; et al. (2003). "Effects of EGIS-7625, a Selective and Competitive 5-HT_2B Receptor Antagonist". Cardiovascular Drugs and Therapy. 17 (5/6): 427–34. doi:10.1023/B:CARD.0000015857.96371.43. PMID 15107597.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[pmid15107597-1] Kovács, Anikó; Gacsályi, Istvan; Wellmann, János; Schmidt, Éva; Szücs, Zsuzsanna; Dubreuil, Valérie; Nicolas, Jean Paul; Boutin, Jean; et al. (2003). "Effects of EGIS-7625, a Selective and Competitive 5-HT_2B Receptor Antagonist". Cardiovascular Drugs and Therapy. 17 (5/6): 427–34. doi:10.1023/B:CARD.0000015857.96371.43. PMID 15107597.

[1]

EGIS-7625

References[edit]

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Navigation

Interaction

Tools

Print/export

Languages